Rituximab vs Sacubitril-Valsartan

## Rituximab vs Sacubitril-Valsartan: Overview

This comparison examines the pharmacological differences between **Rituximab** and **Sacubitril-Valsartan**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

**Sacubitril-Valsartan**: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.

## Pharmacokinetics

**Half-life**: Rituximab — 22 days; Sacubitril-Valsartan — 11.5 hours.

## Chemical Properties

**Molecular Formula**: Rituximab — N/A; Sacubitril-Valsartan — C24H29N2O5.

**Molecular Weight**: Rituximab — N/A; Sacubitril-Valsartan — 414.5010 g/mol.

**Type**: Rituximab — Antibody; Sacubitril-Valsartan — Small molecule.